Hc Advisors, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Hc Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$83.14 - $145.99 $223,979 - $393,297	-2,694 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$110.08 - $142.92 $186,145 - $241,677	-1,691 Reduced 38.56%	2,694 $319,000
Q4 2021 Feb 02, 2022	BUY	$99.73 - $148.48 $69,212 - $103,045	694 Added 18.8%	4,385 $604,000
Q3 2021 Oct 29, 2021	SELL	$98.85 - $138.91 $57,530 - $80,845	-582 Reduced 13.62%	3,691 $513,000
Q2 2021 Aug 09, 2021	SELL	$65.78 - $105.02 $15,129 - $24,154	-230 Reduced 5.11%	4,273 $415,000
Q1 2021 May 07, 2021	BUY	$64.07 - $91.75 $50,102 - $71,748	782 Added 21.02%	4,503 $308,000
Q4 2020 Feb 08, 2021	BUY	$65.07 - $98.24 $20,822 - $31,436	320 Added 9.41%	3,721 $319,000
Q3 2020 Nov 04, 2020	BUY	$59.04 - $77.95 $200,795 - $265,107	3,401 New	3,401 $221,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Hc Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Hc Advisors, LLC with notifications on news.